Tumor necrosis Factor (TnF) Bioactivity at the site of an acute cell-Mediated immune response is Preserved in rheumatoid arthritis Patients responding to anti-TnF Therapy.

MLA

Byng-Maddick, Rachel, et al. “Tumor Necrosis Factor (TnF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TnF Therapy.” Frontiers in Immunology, Aug. 2017, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fimmu.2017.00932.

APA

Byng-Maddick, R., Turner, C. T., Pollara, G., Ellis, M., Guppy, N. J., Bell, L. C. K., Ehrenstein, M. R., & Noursadeghi, M. (2017). Tumor necrosis Factor (TnF) Bioactivity at the site of an acute cell-Mediated immune response is Preserved in rheumatoid arthritis Patients responding to anti-TnF Therapy. Frontiers in Immunology, 1–13. https://doi.org/10.3389/fimmu.2017.00932

Chicago

Byng-Maddick, Rachel, Carolin T. Turner, Gabriele Pollara, Matthew Ellis, Naomi J. Guppy, Lucy C. K. Bell, Michael R. Ehrenstein, and Mahdad Noursadeghi. 2017. “Tumor Necrosis Factor (TnF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TnF Therapy.” Frontiers in Immunology, August, 1–13. doi:10.3389/fimmu.2017.00932.